Cargando…
Bcl-2 family: Novel insight into individualized therapy for ovarian cancer (Review)
Chemoresistance to platinum-based chemotherapy for ovarian cancer in the advanced stage remains a formidable concern clinically. Increasing evidence has revealed that apoptosis represents the terminal events of the anti-tumor mechanisms of a number of chemical drugs and has a close association with...
Autores principales: | Yuan, Jing, Lan, Hua, Jiang, Xiaoyan, Zeng, Da, Xiao, Songshu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447322/ https://www.ncbi.nlm.nih.gov/pubmed/32945348 http://dx.doi.org/10.3892/ijmm.2020.4689 |
Ejemplares similares
-
The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer
por: Lan, Hua, et al.
Publicado: (2021) -
Lipopolysaccharide Affects the Proliferation and Glucose Metabolism of Cervical Cancer Cells Through the FRA1/MDM2/p53 Pathway
por: Jiang, Xiaoyan, et al.
Publicado: (2021) -
Multi-Omics Analysis of the Therapeutic Value of MAL2 Based on Data Mining in Human Cancers
por: Yuan, Jing, et al.
Publicado: (2022) -
The Jun N-terminal kinases signaling pathway plays a “seesaw” role in ovarian carcinoma: a molecular aspect
por: Dou, Yingyu, et al.
Publicado: (2019) -
Clinical analysis of the MyoSure hysteroscopic tissue removal system of endometrial polyps in women with an intact hymen
por: Yong, Jiahui, et al.
Publicado: (2021)